- Tilray Brands (NASDAQ: TLRY) is considering a reverse stock split, ranging from 1-for-10 to 1-for-20.
- Shares of TLRY dropped 10.24% last week, underperforming the broader market and US Pharmaceuticals sector.
- Analysts foresee an average target price of $1.28, indicating a potential 183.43% upside.
Tilray Brands (TLRY, Financial) has announced a special meeting to deliberate on a potential reverse stock split. The proposed split ratios range from 1-for-10 to 1-for-20, illustrating the company’s strategic efforts to enhance its stock price and sustain its market standings. Recently, TLRY shares saw a 10.24% decline over the week, marking a substantial underperformance when compared to both the broader market and the US Pharmaceuticals industry over the past year.
Wall Street Analysts' Forecast
In assessing Tilray Brands Inc (TLRY, Financial), 11 analysts have projected a one-year average price target of $1.28. This projection includes a high estimate of $2.50 and a low of $0.60. The average target signifies an anticipated upside of 183.43% from the current trading price of $0.45. For a comprehensive view of analysts' forecasts, investors can explore more detailed data available on the Tilray Brands Inc (TLRY) Forecast page.
From the perspective of brokerage recommendations, Tilray Brands Inc (TLRY, Financial) holds an average rating of 2.7 from 12 brokerage firms, suggesting a "Hold" consensus. This scale ranges from 1 to 5, where 1 signifies a Strong Buy and 5 indicates Sell, reflecting a cautious but steady investor sentiment.
According to GuruFocus' GF Value estimates, the estimated fair value for Tilray Brands Inc (TLRY, Financial) in one year's time is pegged at $1.91. This estimate indicates a remarkable upside potential of 324.44% from the current price of $0.45, driven by historical trading multiples, past business growth, and anticipated future performance. Investors seeking further insights can access detailed data on the Tilray Brands Inc (TLRY) Summary page.
